CD200, an anti-inflammatory glycoprotein expressed in neurons, T cells, and B cells, has been observed to enhance microglia-mediated Aβ clearance and neural differentiation in patients with AD, exhibiting potential therapeutic effects (Varnum et al., 2015). Here, CD200 is linked to Alzheimer disease.